Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor pathway inhibitor expression in atherosclerosis

A F Drew1, P Davenport, J Apostolopoulos

  • 1Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Victoria, Australia.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Animal models of diet-induced atherosclerosis.

Methods in molecular medicine·2011
Same author

Collection and processing of arterial specimens for histological analysis.

Methods in molecular medicine·2011
Same author

1Nonradioactive In Situ Hybridization in Atherosclerotic Tissue.

Methods in molecular medicine·2011
Same author

Workshop: tuning the 'cough center'.

Pulmonary pharmacology & therapeutics·2011
Same author

A pilot study of high-adsorption hemofiltration in human septic shock.

The International journal of artificial organs·2007
Same author

Glomerulonephritis, Th1 and Th2: what's new?

Clinical and experimental immunology·2005

Tissue factor pathway inhibitor (TFPI) is expressed in arteries and macrophages within atherosclerotic plaques. Local TFPI production may regulate coagulation and thrombosis in atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Hemostasis and Thrombosis
  • Atherosclerosis Research

Background:

  • Tissue factor pathway inhibitor (TFPI) inhibits tissue factor (TF)-initiated coagulation.
  • TFPI may regulate coagulation within atherosclerotic plaques.
  • Understanding TFPI expression in atherosclerosis is crucial for therapeutic development.

Purpose of the Study:

  • To examine the expression and localization of TFPI protein and mRNA in normal and atherosclerotic arteries.
  • To investigate the cellular sources of TFPI in atherosclerotic lesions.
  • To determine the role of TFPI in regulating coagulation within plaques.

Main Methods:

  • Immunohistology and in situ hybridization were used to detect TFPI protein and mRNA.
  • Studies were conducted on normal human and rabbit arteries.

Related Experiment Videos

  • Atherosclerotic human carotid arteries and rabbit aortas from cholesterol-fed rabbits were analyzed.

    • Main Results:

    • TFPI was detected in the adventitia of normal arteries but not in the endothelium.
    • In atherosclerotic plaques, TFPI protein and mRNA were found in focal areas, colocalizing with macrophages.
    • TFPI expression was also observed in macrophage-rich fatty streaks in rabbits.

    Conclusions:

    • TFPI is expressed in the adventitia of large arteries.
    • Macrophages in atherosclerotic plaques are a significant source of TFPI.
    • Local TFPI production may modulate procoagulant activity and thrombotic events in atherosclerosis.